BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35726891)

  • 21. The histone demethylase KDM5A is required for the repression of astrocytogenesis and regulated by the translational machinery in neural progenitor cells.
    Kong SY; Kim W; Lee HR; Kim HJ
    FASEB J; 2018 Feb; 32(2):1108-1119. PubMed ID: 29212818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lysine demethylase 5A promotes prostate adenocarcinoma progression by suppressing microRNA-330-3p expression and activating the COPB2/PI3K/AKT axis in an ETS1-dependent manner.
    Mi Y; Zhang L; Sun C; Feng Y; Sun J; Wang J; Yang D; Qi X; Wan H; Xia G; Wu S; Zhu L
    J Cell Commun Signal; 2022 Dec; 16(4):579-599. PubMed ID: 35581421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aβ-induced mitochondrial dysfunction in neural progenitors controls KDM5A to influence neuronal differentiation.
    Kim DK; Jeong H; Bae J; Cha MY; Kang M; Shin D; Ha S; Hyeon SJ; Kim H; Suh K; Choi MS; Ryu H; Yu SW; Kim JI; Kim YS; Lee SW; Hwang D; Mook-Jung I
    Exp Mol Med; 2022 Sep; 54(9):1461-1471. PubMed ID: 36056186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PI3K/AKT Signaling Regulates H3K4 Methylation in Breast Cancer.
    Spangle JM; Dreijerink KM; Groner AC; Cheng H; Ohlson CE; Reyes J; Lin CY; Bradner J; Zhao JJ; Roberts TM; Brown M
    Cell Rep; 2016 Jun; 15(12):2692-704. PubMed ID: 27292631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The KDM5A/RBP2 histone demethylase represses NOTCH signaling to sustain neuroendocrine differentiation and promote small cell lung cancer tumorigenesis.
    Oser MG; Sabet AH; Gao W; Chakraborty AA; Schinzel AC; Jennings RB; Fonseca R; Bonal DM; Booker MA; Flaifel A; Novak JS; Christensen CL; Zhang H; Herbert ZT; Tolstorukov MY; Buss EJ; Wong KK; Bronson RT; Nguyen QD; Signoretti S; Kaelin WG
    Genes Dev; 2019 Dec; 33(23-24):1718-1738. PubMed ID: 31727771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Domain architecture and protein-protein interactions regulate KDM5A recruitment to the chromatin.
    Kataria A; Tyagi S
    Epigenetics; 2023 Dec; 18(1):2268813. PubMed ID: 37838974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
    Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
    Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. KDM5A promotes proliferation and EMT in ovarian cancer and closely correlates with PTX resistance.
    Feng T; Wang Y; Lang Y; Zhang Y
    Mol Med Rep; 2017 Sep; 16(3):3573-3580. PubMed ID: 28714030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histone H3 binding to the PHD1 domain of histone demethylase KDM5A enables active site remodeling.
    Longbotham JE; Chio CM; Dharmarajan V; Trnka MJ; Torres IO; Goswami D; Ruiz K; Burlingame AL; Griffin PR; Fujimori DG
    Nat Commun; 2019 Jan; 10(1):94. PubMed ID: 30626866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histone demethylase KDM5A regulates the ZMYND8-NuRD chromatin remodeler to promote DNA repair.
    Gong F; Clouaire T; Aguirrebengoa M; Legube G; Miller KM
    J Cell Biol; 2017 Jul; 216(7):1959-1974. PubMed ID: 28572115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancing KDM5A and TLR activity improves the response to immune checkpoint blockade.
    Wang L; Gao Y; Zhang G; Li D; Wang Z; Zhang J; Hermida LC; He L; Wang Z; Si J; Geng S; Ai R; Ning F; Cheng C; Deng H; Dimitrov DS; Sun Y; Huang Y; Wang D; Hu X; Wei Z; Wang W; Liao X
    Sci Transl Med; 2020 Sep; 12(560):. PubMed ID: 32908002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma.
    Han LY; Fletcher MS; Urbauer DL; Mueller P; Landen CN; Kamat AA; Lin YG; Merritt WM; Spannuth WA; Deavers MT; De Geest K; Gershenson DM; Lutgendorf SK; Ferrone S; Sood AK
    Clin Cancer Res; 2008 Jun; 14(11):3372-9. PubMed ID: 18519766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular mechanisms of KDM5A in cellular functions: Facets during development and disease.
    Kirtana R; Manna S; Patra SK
    Exp Cell Res; 2020 Nov; 396(2):112314. PubMed ID: 33010254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Joining the PARty: PARP Regulation of KDM5A during DNA Repair (and Transcription?).
    Sanchez A; Buck-Koehntop BA; Miller KM
    Bioessays; 2022 Jul; 44(7):e2200015. PubMed ID: 35532219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genomic amplification and a role in drug-resistance for the KDM5A histone demethylase in breast cancer.
    Hou J; Wu J; Dombkowski A; Zhang K; Holowatyj A; Boerner JL; Yang ZQ
    Am J Transl Res; 2012; 4(3):247-56. PubMed ID: 22937203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. KDM5A suppresses PML-RARα target gene expression and APL differentiation through repressing H3K4me2.
    Xu S; Wang S; Xing S; Yu D; Rong B; Gao H; Sheng M; Tan Y; Sun X; Wang K; Xue K; Shi Z; Lan F
    Blood Adv; 2021 Sep; 5(17):3241-3253. PubMed ID: 34448811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunomodulatory action of the DNA methyltransferase inhibitor SGI-110 in epithelial ovarian cancer cells and xenografts.
    Srivastava P; Paluch BE; Matsuzaki J; James SR; Collamat-Lai G; Taverna P; Karpf AR; Griffiths EA
    Epigenetics; 2015; 10(3):237-46. PubMed ID: 25793777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ELK4 promotes the development of gastric cancer by inducing M2 polarization of macrophages through regulation of the KDM5A-PJA2-KSR1 axis.
    Zheng L; Xu H; Di Y; Chen L; Liu J; Kang L; Gao L
    J Transl Med; 2021 Aug; 19(1):342. PubMed ID: 34372882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long non-coding RNA tumor protein 73 antisense RNA 1 influences an interaction between lysine demethylase 5A and promoter of tumor protein 73 to enhance the malignancy of colorectal cancer.
    Huang Z; Wang H; Yang M
    Hum Cell; 2022 Sep; 35(5):1512-1520. PubMed ID: 35896939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The SETDB1-TRIM28 Complex Suppresses Antitumor Immunity.
    Lin J; Guo D; Liu H; Zhou W; Wang C; Müller I; Kossenkov AV; Drapkin R; Bitler BG; Helin K; Zhang R
    Cancer Immunol Res; 2021 Dec; 9(12):1413-1424. PubMed ID: 34848497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.